American Journal of Medicine Studies
ISSN (Print): 2333-8881 ISSN (Online): 2333-889X Website: http://www.sciepub.com/journal/ajms Editor-in-chief: Apply for this position
Open Access
Journal Browser
Go
American Journal of Medicine Studies. 2014, 2(1), 12-18
DOI: 10.12691/ajms-2-1-2
Open AccessArticle

Effect of Combination between Methotrexate and Histone Deacetylase Inhibitors on Transplantable Tumor Model

Ahmed M Kabel1,

1Pharmacology Department, Faculty of Medicine, Tanta University, Tanta, Egypt

Pub. Date: January 01, 2014

Cite this paper:
Ahmed M Kabel. Effect of Combination between Methotrexate and Histone Deacetylase Inhibitors on Transplantable Tumor Model. American Journal of Medicine Studies. 2014; 2(1):12-18. doi: 10.12691/ajms-2-1-2

Abstract

Solid Ehrlich carcinoma is an undifferentiated tumor used in tumor studies. Methotrexate is an antimetabolite used in treatment of cancer, autoimmune diseases and induction of abortion. Valproic acid is used as anticonvulsant and is under investigation for treatment of cancer. The aim of this work was to study the effect of each of methotrexate and valproic acid alone and in combination on solid Ehrlich tumor in mice. Fifty albino mice were divided into five equal groups: Control untreated group, solid Ehrlich carcinoma, solid Ehrlich carcinoma + methotrexate, solid Ehrlich carcinoma + valproic acid, solid Ehrlich carcinoma + methotrexate + valproic acid. Tumor volume, tissue catalase, glutathione reductase, malondialdehyde, cholesterol and tumor necrosis factor-α were determined. A part of the tumor was examined for histopathological and immunohistochemical study. Methotrexate or valproic acid alone or in combination induced significant increase in tissue catalase and glutathione reductase with significant decrease in tumor volume, tissue malondialdehyde, cholesterol and tumor necrosis factor-α and alleviated the histopathological changes with significant increase in p53 expression and apoptotic index compared to solid Ehrlich carcinoma group. The combination of methotrexate and valproic acid has a better effect than each of methotrexate or valproic acid alone against solid Ehrlich tumor in mice.

Keywords:
methotrexate histone deacetylase tumor mice

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

Figure of 3

References:

[1]  Silva LA, Nascimento KA, Maciel MC, Pinheiro MT, Sousa PR, Ferreira SC, et al: Sunflower Seed Oil-Enriched Product Can Inhibit Ehrlich Solid Tumor Growth in Mice. Chemotherapy 2006; 52: 91-94.
 
[2]  Sakai M, Ferraz-de-Paula V, Pinheiro ML, Ribeiro A, Quinteiro-Filho WM, Rone MB, et al.: Translocator protein (18 kDa) mediates the pro-growth effects of diazepam on Ehrlich tumor cells in vivo. Euro J Pharmacol 2010; 626 (2-3): 131-138.
 
[3]  Mol F, Mol BW, Ankum WM, van der Veen F, Hajenius PJ: Current evidence on surgery, systemic MTX and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis. Hum Reprod Update 2008; 14 (4): 309-19.
 
[4]  Kabel AM, Abdel-Rahman MN, El-Sisi AE, Haleem MS, Ezzat NM, El Rashidy MA: Effect of atorvastatin and methotrexate on solid Ehrlich tumor. Eur J Pharmacol. 2013; 713(1-3):47-53.
 
[5]  Perucca E: Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs 2002; 16 (10): 695-714.
 
[6]  Sagot-Lerolle N, Lamine A, Chaix ML, Boufassa F, Aboulker JP, Costagliola D, et al.: Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir. AIDS 2008; 22 (10): 1125-29.
 
[7]  Blaheta RA, Michaelis M, Driever PH, Jr JC: Evolving Anticancer Drug Valproic Acid: Insights into the Mechanism and Clinical Studies. Medicinal Research Reviews 2005; 25(4): 383-397.
 
[8]  Srikanth K, Debnath B, Nayak SS, Tarun JHA: Enhanced regression of tumors in mice with combined chemotherapy & immunotherapy. Ind J Pharmacol 2002; 34: 172-177.
 
[9]  Basselin M, Chang L, Chen M, Bell JM, Rapport S: Chronic administration of valproic acid reduces brain NMDA signaling via arachidonic acid in unanesthetized rats. Neurochem Res 2008; 33(11): 2229-2240.
 
[10]  Osman A, Sayed-Ahmed M, Khayyal M, El Merzebani M: Hyperthermic potentiation of cisplatin on solid Ehrlich carcinoma. Tumori 1993; 79: 268-72.
 
[11]  Attia M, Weiss DW: Immunology of spontaneous mammary carcinomas in mice infected with mammary tumor virus. Cancer Res 1966; 26:1787-800.
 
[12]  Higgins CP, Bachner R, McCallister J: Polymorpho-nuclear leukocyte species differences in the disposal of hydrogen peroxide (H2O2). Proc Soc Exp Biol Med 1978; 158: 478-481.
 
[13]  Uchiyama M, Mihara M: Determination of malondialdehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1979; 86: 271-278.
 
[14]  Manso C, Wroblewski F: Glutathione reductase activity in blood and body Fluids. J Clin Investigation 1958; 37: 214-218.
 
[15]  Richmond W: Preparation and properties of a cholesterol oxidase from Nocardia sp and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 1973; 19 (12): 1350-1356.
 
[16]  Luster AD, Rothenberg ME: Role of the monocyte chemoattractant preotein ane eotaxin subfamily chemokines in allergic inflammation. J Leukoc Biol 1997; 62:620.
 
[17]  Sarraf CE, Bowen ID: Kinetic studies on murine sarcoma and an analysis of apoptosis. Br J Cancer 1988; 54: 989-98.
 
[18]  Manne U, Weiss HL, Myers RB, Danner OK: Nuclear accumulation of p53 in colorectal adenocarcinomas: prognostic importance differs with race and location of tumor. Cancer 1998; 83: 2456-67.
 
[19]  Ozaslan M, Karagoz ID, Kilic IH, Guldur ME: Ehrlich ascites carcinoma. Afr J Biotechnol 2011; 10(13): 2375-2378.
 
[20]  Segura JA, Ruiz-Bellido MA, Arenas M, Lobo C, Marquez J, Alonso FJ: Ehrlich Ascites Tumor Cells Expressing Anti-Sense Glutaminase RNA Lose Their Capacity to Evade the Mouse Immune System. Int J Cancer 2001; 91: 379-384.
 
[21]  Badr El-Din NK: Protective role of sanumgerman against γ-irradiation–induced oxidative stress in Ehrlich carcinoma-bearing mice. Nutrition Research 2004; 24: 271-291.
 
[22]  Zahran MA, Salem TA, Samaka RM, Agwa HS, Awad AR: Design, synthesis and antitumor evaluation of novel thalidomide dithiocarbamate and dithioate analogs against Ehrlich ascites carcinoma-induced solid tumor in Swiss albino mice. Bioorg Med Chem 2008; 16(22): 9708-9718.
 
[23]  Matés JM, Segura JA, Alonso FJ, Márquez J: Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis. Arch Toxicol. 2008; 82(5): 273-99.
 
[24]  Sarkar S, Yadav P, Bhatnagar D: Effect of cadmium on glutathione metabolism and glucose 6-phosphate dehydrogenase in rat tissues: role of vitamin E and selenium. Trace Elem Electrol 1998; 15: 101-105.
 
[25]  Takahashi HK, Nishibori M: The antitumor activities of statins. Curr Oncol 2007; 14 (6): 246-247.
 
[26]  Luo JL, Maeda S, Hsu LC, Yagita H, Karin M: Inhibition of NF-κB in cancer cells converts inflammation-induced tumor growth mediated by TNF- α to TRAIL-mediated tumor regression. Cancer Cell 2004; 6: 297-305.
 
[27]  Waterston A, Bower M: TNF and cancer: good or bad?. Cancer Therapy 2004; 2:131-148.
 
[28]  Ravi R, Zhiquan Z, Lynn MC, Mary D,Benkovic SJ, Hammes G: Interaction of dihydrofolate reductase with MTX: Ensemble and single-molecule kinetics. Proceedings of the National Academy of Sciences 2002; 99 (21): 13481-6.
 
[29]  Basak C, Andeerea KL, Qing W, Rima R: Methotrexate-induced apoptosis is enhanced by altered expression of methylene tetrahydrofolate reductase. Anti- Cancer Drugs 2009; 20: 787-793.
 
[30]  Winter-Vann AM, Kamen BA, Bergo MO, Young SG, Melenyk S, James SJ, et al.: Targeting Ras signaling through inhibition of carboxyl methylation: an unexpected property of methotrexate. PNAS 2003; 100: 6529-6234.
 
[31]  Sung JY, Hong JH, Kang HS, Choi I, Lim SD, Lee JK, et al.: Methotrexate suppresses the interleukin-6 induced generation of reactive oxygen species in the synoviocytes of rheumatoid arthritis. Immunopharmacology 2000; 47: 35-44.
 
[32]  Cutolo M, Sulli A, Pizzorni C, Seriolo B: Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis. Ann Rheum Dis 2001; 60: 729-735.
 
[33]  Schnyder B, Drexel J, Sauter C: Influence of cyclophosphamide, methotrexate, and 5-fluorouracil on serum cholesterol (Meeting abstract). ASCO Annual Meeting 1996; No. 312.
 
[34]  Glozak MA, Seto E: Histone deacetylases and cancer. Oncogene 2007; 26: 5420-5432.
 
[35]  Cinatl J, Kotchetkov R, Blaheta R, Driever PH, Vogel JU, Cinatl J: Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: Enhancement by combination with interferon-alpha. Int J Oncol 2002; 20:97-106.
 
[36]  Fourcade S, Ruiz M, Guilera C, Hahnen E, Brichta L, Naudi A, et al.: Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy. Human Molecular Genetics 2010; 19 (10): 2005-2014.
 
[37]  Glauben R, Batra A, Fedke I, Zeitz M, Lehr HA, Leoni F, et al.: Histone Hyperacetylation Is Associated with Amelioration of Experimental Colitis in Mice. J Immunol 2006; 176:5015-5022.
 
[38]  Zhang Z, Zhang ZY, Fauser U, Schluesener HJ: Valproic acid attenuates inflammation in experimental autoimmune neuritis. Cell Mol Life Sci 2008; 65: 4055-4065.
 
[39]  Zgouras D, Becker U, Loitsch S, Stein J: Modulation of angiogenesis-related protein synthesis by valproic acid. Biochem Biophys Res Commun 2004;316: 693-697.
 
[40]  Gurvich N, Tsygankova OM, Meinkoth JL, Klein PS: Histone deacetylase is a target of valproic acidmediated cellular differentiation. Cancer Res 2004;64: 1079-1086.
 
[41]  Beger RD, Hansen DK, Schnackenberg LK, Cross BM, Fatollahi J, Lagunero FT, et al.: Single valproic acid treatment inhibits glycogen and RNA ribose turnover while disrupting glucose-derived cholesterol synthesis in liver as revealed by the [U-13C6]-d-glucose tracer in mice. Metabolomics 2009; 5(3): 336-345.
 
[42]  Pipalia NH, Cosner C, Huang A, Chatterjee A, Bourbon P, Farley N, et al.: Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts. PNAS 2011; 108(14): 5620-5625.